Business Description
Timber Pharmaceuticals Inc
NAICS : 541714
SIC : 2833
ISIN : US8870802084
Share Class Description:
FRA:BPC: Ordinary SharesDescription
Trex Wind Down Inc formerly, Timber Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its investigational therapies haveĀ mechanisms of action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. The company is focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), X-linked recessive CI (XLRI) autosomal recessive CI (ARCI), and other sclerotic skin diseases. The company'sĀ late-stage program is TMB-001., and TMB-003 is the earliest-stage program.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 65.67 | |||||
| 12-1 Month Momentum % | 43.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-Revenue | 0.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Timber Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ā¬) | |||
| EPS (TTM) (ā¬) | -5.138 | ||
| Beta | 0 | ||
| Volatility % | 178.83 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (ā¬) | 0.151857 | ||
| 20-Day SMA (ā¬) | 0 | ||
| 12-1 Month Momentum % | 43.41 | ||
| 52-Week Range (ā¬) | 0.28 - 2.92 | ||
| Shares Outstanding (Mil) | 3.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Timber Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Timber Pharmaceuticals Inc Stock Events
| Event | Date | Price(ā¬) | ||
|---|---|---|---|---|
| No Event Data | ||||
Timber Pharmaceuticals Inc Frequently Asked Questions
What is Timber Pharmaceuticals Inc(FRA:BPC)'s stock price today?
The current price of FRA:BPC is ā¬0.29. The 52 week high of FRA:BPC is ā¬2.92 and 52 week low is ā¬0.28.
When is next earnings date of Timber Pharmaceuticals Inc(FRA:BPC)?
The next earnings date of Timber Pharmaceuticals Inc(FRA:BPC) is 2024-11-28 Est..
Does Timber Pharmaceuticals Inc(FRA:BPC) pay dividends? If so, how much?
Timber Pharmaceuticals Inc(FRA:BPC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers